1. Home
  2. ELTX vs ESOA Comparison

ELTX vs ESOA Comparison

Compare ELTX & ESOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • ESOA
  • Stock Information
  • Founded
  • ELTX 2011
  • ESOA 2006
  • Country
  • ELTX United States
  • ESOA United States
  • Employees
  • ELTX N/A
  • ESOA N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • ESOA Water Sewer Pipeline Comm & Power Line Construction
  • Sector
  • ELTX Health Care
  • ESOA Industrials
  • Exchange
  • ELTX Nasdaq
  • ESOA Nasdaq
  • Market Cap
  • ELTX 121.7M
  • ESOA 135.6M
  • IPO Year
  • ELTX N/A
  • ESOA 2006
  • Fundamental
  • Price
  • ELTX $5.40
  • ESOA $9.42
  • Analyst Decision
  • ELTX Strong Buy
  • ESOA
  • Analyst Count
  • ELTX 2
  • ESOA 0
  • Target Price
  • ELTX $9.50
  • ESOA N/A
  • AVG Volume (30 Days)
  • ELTX 35.2K
  • ESOA 154.3K
  • Earning Date
  • ELTX 05-19-2025
  • ESOA 05-20-2025
  • Dividend Yield
  • ELTX N/A
  • ESOA 0.32%
  • EPS Growth
  • ELTX N/A
  • ESOA 161.70
  • EPS
  • ELTX N/A
  • ESOA 1.44
  • Revenue
  • ELTX N/A
  • ESOA $362,359,788.00
  • Revenue This Year
  • ELTX N/A
  • ESOA $9.95
  • Revenue Next Year
  • ELTX N/A
  • ESOA N/A
  • P/E Ratio
  • ELTX N/A
  • ESOA $6.84
  • Revenue Growth
  • ELTX N/A
  • ESOA 8.42
  • 52 Week Low
  • ELTX $3.34
  • ESOA $5.70
  • 52 Week High
  • ELTX $11.45
  • ESOA $19.83
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 48.43
  • ESOA 53.18
  • Support Level
  • ELTX $4.85
  • ESOA $8.31
  • Resistance Level
  • ELTX $5.94
  • ESOA $9.91
  • Average True Range (ATR)
  • ELTX 0.50
  • ESOA 0.57
  • MACD
  • ELTX 0.14
  • ESOA 0.13
  • Stochastic Oscillator
  • ELTX 56.45
  • ESOA 71.51

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About ESOA Energy Services of America Corporation

Energy Services of America Corporation is engaged in providing contracting services for energy-related companies. The company is predominantly engaged in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It services the gas, petroleum, power, chemical, and automotive industries and does incidental work such as water and sewer projects. Energy Service's other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, various maintenance and repair services, and other services related to pipeline construction.

Share on Social Networks: